登录

YIBEI Raises ¥10M in Series A Round of Financing

作者: Mailman 2021-02-26 14:59
医联
https://www.medlinker.com
企业数据由 动脉橙 提供支持
慢病管理平台提供商 | E轮 | 运营中
中国-四川
2021-12-12
融资金额:$5.14亿
中国生物制药
查看

(VCBeat) Feb. 22, 2021 -- Recently, YIBEI announced it has closed tens of millions of yuan in Series A funding, led by Hai Bang Capital, with participation from Medlinker and Pudu Capital. 


Founded in 2019, YIBEI is committed to providing digital procurement and supply chain operation solutions for upstream and downstream medical enterprises, with most of its core team members coming from well-known medical and Internet medical companies. The company has always adhered to the core concept of "using digital technology, providing competitive products and services, and continuously creating maximum value for clients", with its products being applied in more than 100 medical institutions and thousands of medical enterprises.


Li Zongli, founder and CEO of YIBEI, said that at present, the data-driven medical procurement SAAS and supply chain operation system is still in the early stage of development, after this round of financing, YIBEI will further invest in the R&D of intelligent and big data-based applications, improve the customer experience, build interconnectivity of upstream and downstream through the medical purchasing platform and operation service system, and accelerate the market expansion.


The VWork intelligent supply chain management system self-developed by YIBEIcovers the digital management needs of medical institutions, such as supplies, instruments, drugs, logistics, etc. The system adopts modular design and development, and can be independently configured according to different needs of hospitals in each development stage. Its unique AI-powered procurement function helps medical institutions to achieve multi-dimensional price comparison, reduce costs, and improve operational efficiency.


YiEDP (the enterprise digital platform developed by YIBEI), based on big data of drugs and medical devices, providing cloud services of marketing, intelligent procurement, supply chain management, customer relationship management (CRM), cloud certificates, and finance, which realize the Information connectivity at all levels and the precise and efficient digital management for clients.


>>>>

About Hai Bang Capital


Hai Bang Capital is an investment company focusing on venture investment and private equity. In 2011, Hai Bang Capital launched its first Hai Bang Talent Fund. Hai Bang Capital is focused on technology innovation, connecting capital and technology. In addition to providing capital, Hai Bang Capital provides its invested companies with personalized value-added services, stimulating both the national economy and social benefits.

注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

【首发】赋能生命科学临床研究数智化,耀乘健康科技完成数千万美元A+轮融资

【首发】生物科技数据平台斑马鱼数字智能获嘉程近千万元天使轮投资

【首发】消费医疗SaaS+交易平台领健完成D+轮融资

【首发】领健完成1亿美元融资,打造“管理软件”与“耗材商城”双冠王

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Sinotau Closes ¥320M Series D Financing

2021-02-26
下一篇

Pushkang Secures ¥100 Million in Series C Funding Round

2021-02-26